EDGAR Filing Documents for 0001144204-13-020910

Form F-1 - Registration statement for certain foreign private issuers:

SEC Accession No. 0001144204-13-020910

Filing Date

2013-04-10

Accepted

2013-04-09 18:32:41

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM F-1	v340830_f1.htm	F-1	1700531
2	EXHIBIT 4.40	v340830_ex4-40.htm	EX-4.40	124614
3	EXHIBIT 4.41	v340830_ex4-41.htm	EX-4.41	149255
4	EXHIBIT 4.42	v340830_ex4-42.htm	EX-4.42	135763
5	EXHIBIT 5.1	v340830_ex5-1.htm	EX-5.1	41356
6	EXHIBIT 23.1	v340830_ex23-1.htm	EX-23.1	2843
7	GRAPHIC	tpg131.jpg	GRAPHIC	6434
	Complete submission text file	0001144204-13-020910.txt		2164330

Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036

Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804

Morria Biopharmaceuticals PLC (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-1 | Act: 33 | File No.: 333-187826 | Film No.: 13751958
SIC: 2834 Pharmaceutical Preparations